APP and amyloidosis: However, it has been reported that other well-established amyloidosis models, such as APPswe/PS1ΔE9 mice, expressing comparable APP and PS transgenes and also exhibiting decent and progressive pathology, did not differentiate significantly from wild-type animals and were therefore rated to be unsuitable for FBB PET.